Search

Your search keyword '"A. K. Pal"' showing total 760 results

Search Constraints

Start Over You searched for: Author "A. K. Pal" Remove constraint Author: "A. K. Pal" Topic medicine.disease Remove constraint Topic: medicine.disease
760 results on '"A. K. Pal"'

Search Results

1. 'Collecting duct carcinoma of the kidney: diagnosis and implications for management'

2. Infigratinib in Early-Line and Salvage Therapy for FGFR3-Altered Metastatic Urothelial Carcinoma

3. Cabozantinib plus immunotherapy combinations in metastatic renal cell and urothelial carcinoma

4. Fighting the ‘tobacco epidemic’ – A call to action to identify Targeted Intervention Points (TIPs) for better counseling patients with urothelial cancer

5. Clinical Utility of Cell-free and Circulating Tumor DNA in Kidney and Bladder Cancer: A Critical Review of Current Literature

6. Recall of Genomic Testing Results Among Patients with Cancer

7. Ischemic Cardiomyopathy in a Case of Takayasu's Arteritis

8. Qualitative Traits of Dry Rose Flowers ‘Taj Mahal’ as Influenced by Dehydration Methods

9. A drug delivery perspective on intratumoral-immunotherapy in renal cell carcinoma

10. Efficacy of immune-checkpoint inhibitors (ICI) in the treatment of older adults with metastatic renal cell carcinoma (mRCC) – an International mRCC Database Consortium (IMDC) analysis

11. Efficacy and Safety of Atezolizumab Plus Bevacizumab Following Disease Progression on Atezolizumab or Sunitinib Monotherapy in Patients with Metastatic Renal Cell Carcinoma in IMmotion150: A Randomized Phase 2 Clinical Trial

12. Emotional problem‐related distress screening and its prevalence by cancer type: Assessment by patients' characteristics and level of assistance requested

13. Genetic Differences Between Bladder and Upper Urinary Tract Carcinoma: Implications for Therapy

14. Urothelial Cancers with Small Cell Variant Histology Have Confirmed High Tumor Mutational Burden, Frequent TP53 and RB Mutations, and a Unique Gene Expression Profile

15. Active surveillance of metastatic renal cell carcinoma: Results from a prospective observational study (MaRCC)

16. Adjuvant Therapy in Renal Cell Carcinoma: Current Status and Future Directions

17. Neurodevelopmental origins of self‐limiting rolandic epilepsy: Systematic review of MR imaging studies

18. COVID-19 vaccine guidance for patients with cancer participating in oncology clinical trials

19. Efficacy and Safety of Nivolumab Plus Ipilimumab versus Sunitinib in First-line Treatment of Patients with Advanced Sarcomatoid Renal Cell Carcinoma

20. Role of Ventromedial Hypothalamus in Sucrose-Induced Obesity on Metabolic Parameters

21. Cabozantinib real‐world effectiveness in the first‐through fourth‐line settings for the treatment of metastatic renal cell carcinoma: Results from the International Metastatic Renal Cell Carcinoma Database Consortium

22. Chemoimmunotherapy in urothelial cancer: concurrent or sequential?

23. Outlining Impact of Hybrid Composition of Nanoparticles Suspended in Blood Flowing in an Inclined Stenosed Artery Under Magnetic Field Orientation

24. Phase I Study of Cabozantinib and Nivolumab Alone or With Ipilimumab for Advanced or Metastatic Urothelial Carcinoma and Other Genitourinary Tumors

25. Engaging Patients in Precision Oncology: Development and Usability of a Web-Based Patient-Facing Genomic Sequencing Report

26. Fear of Cancer Recurrence in Patients With Localized Renal Cell Carcinoma

27. Randomized trial assessing impact of probiotic supplementation on gut microbiome and clinical outcome from targeted therapy in metastatic renal cell carcinoma

28. Discrepancies between genitourinary cancer patients' and clinicians' characterization of the Eastern Cooperative Oncology Group performance status

29. Blood-based gene expression signature associated with metastatic castrate-resistant prostate cancer patient response to abiraterone plus prednisone or enzalutamide

30. Stool Microbiome Profiling of Patients with Metastatic Renal Cell Carcinoma Receiving Anti–PD-1 Immune Checkpoint Inhibitors

31. Increased osteoprotegerin level is associated with impaired cardiovagal modulation in type-2 diabetic patients treated with oral antidiabetic drugs

32. Race/Ethnicity and Survival in Metastatic Renal Cell Carcinoma: Outcomes for Patients Receiving First Line Targeted Therapies

33. Immunotherapy‐based combination strategies for advanced urothelial cancer: A long quest

34. Sequencing Therapies for Metastatic Renal Cell Carcinoma

35. Updated efficacy results from the JAVELIN Renal 101 trial: first-line avelumab plus axitinib versus sunitinib in patients with advanced renal cell carcinoma

36. Dietary Choices Modulate Colorectal Cancer Stem Cells: A Role of FXR Nuclear Receptor

37. Examining the Association of Academic Rank and Productivity with Metrics of Twitter Utilization Amongst Kidney Cancer Specialists

38. Genomic profiling in renal cell carcinoma

39. Diabetes in tuberculosis patients: An emerging public health concern and the determinants and impact on treatment outcome

40. Summary From the First Kidney Cancer Research Summit, September 12–13, 2019: A Focus on Translational Research

41. Patient‐reported outcomes in a phase 2 study comparing atezolizumab alone or with bevacizumab vs sunitinib in previously untreated metastatic renal cell carcinoma

42. Biomarker approach harnessed in trials of personalized medicine for bladder cancer

43. Androgen Receptor and PI3K Pathway Activity in Ovarian Cancer

44. The L1624Q Variant in SCN1A Causes Familial Epilepsy Through a Mixed Gain and Loss of Channel Function

45. 513 Trial in progress: phase 1 first-in-human study of XL092 administered alone or in combination with immune checkpoint inhibitors in patients with inoperable locally advanced or metastatic solid tumors

47. Treatment Pattern and Outcomes with Systemic Therapy in Men with Metastatic Prostate Cancer in the Real-World Patients in the United States

48. MP45-11 WHICH CLINICAL CHARACTERISTICS SHOULD PROMPT MULTIDISCIPLINARY TEAM EVALUATION AFTER DIAGNOSING NON-METASTATIC RENAL CELL CARCINOMA: IMPLICATIONS FOR PATIENT REFERRAL, PRE-SURGICAL TRIALS AND HEALTH CARE POLICIES

49. Interactive Data Visualization Tool for Patient-Centered Decision Making in Kidney Cancer

50. Effect of Cisplatin and Gemcitabine With or Without Berzosertib in Patients With Advanced Urothelial Carcinoma: A Phase 2 Randomized Clinical Trial

Catalog

Books, media, physical & digital resources